You are here: Industry Insights > Sanofi

News List

Sanofi and other drugmakers stockpile drugs in preparation for Brexit chaos fiercepharma
August 02, 2018
Another drugmaker has confirmed some of its manufacturing facilities are stockpiling key drugs and vaccines as it looks like the U.K. and Europe are barreling toward a head-on collision with Brexit.
Sanofi and other drugmakers stockpile drugs in preparation for Brexit chaos fiercepharma
August 02, 2018
Another drugmaker has confirmed some of its manufacturing facilities are stockpiling key drugs and vaccines as it looks like the U.K. and Europe are barreling toward a head-on collision with Brexit.
Thanks to Genzyme—and no thanks to vaccines or diabetes—Sanofi is treading water fiercepharma
August 01, 2018
As much as Sanofi has struggled with diabetes and generic drugs the past few years, it could typically count on vaccines and Genzyme to come to the rescue. This quarter, Genzyme played its usual lifeguard role, but vaccines fell down on the job.
Sanofi ships first of 70M doses of flu shots for the 2018-19 season fiercepharma
August 01, 2018
Sanofi Pasteur has shipped the first of its flu vaccines for the 2018-2019 season, with plans to make about 70 million doses.
Sanofi profits and sales fall in Q2 pharmatimes
August 01, 2018
Sanofi saw its profits and sales fall in Q2 in the wake of several high-profile exclusivity losses.
HitGen Enters DNA-Encoded Library Drug Discovery Research Collaboration With Sanofi HitGen
July 27, 2018
July 27th, 2018, HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Sanofi to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology pl
Sanofi, Regeneron to cut price of Praluent pharmatimes
July 24, 2018
Selina McKee Sanofi and Regeneron have pledged to make Praluent more accessible to patients as data show that the drug significantly cut the risk of cardiovascular events in high-risk patients.
Sanofi, Translate Bio ink mRNA vaccine R&D deal worth up to $805M fiercevaccines
July 23, 2018
Moving to expand its vaccine pipeline after some slip-ups last year, Sanofi is betting on Translate Bio's mRNA platform in up to five undisclosed infectious disease targets.
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report fiercevaccines
July 23, 2018
Shingrix may not make it on the top five best-selling vaccines list in 2024, but a diversified portfolio will still secure GlaxoSmithKline the lead position in the vaccine industry at that time, followed by Merck &Co., Sanofi, Pfizer and a dark horse biot
EU reviews for Sanofi’s Dupixent, cemiplimab pharmatimes
July 19, 2018
European regulators have agreed to review Sanofi and Regeneron’s Dupixent for asthma and cemiplimab for advanced cutaneous squamous cell carcinoma.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page